Table 3. Open in new tab Changes in...

	ONS	ONS + RE
Hemoglobin (g/dL)	8.1 (7–10)	9.2 (8–10)^a	1.1 (−0.4–2.8)	8.4 (7.4–10)	0.2 (−0.7–1.2)	7.4 (6.6–9.1)	9 (7.6–10)^b	1.1 (0.3–1.7)	9 (7.7–10)	1.3 (−0.05–2.3)
Total lymphocytescount (cells/mm³)	977.6 (767–1165)	878.4 (764–1068)	−81.4 (−317.1–220.3)	996.3 (886.2–1161)	35.3 (−140.5–228.6)	702 (586.5–1022.85)	877.2 (654.5–1014)	50.1 (−169.8–203.2)	720 (637.2–798.5)	−25.5 (319.3–68.55)
Creatinine (mg/dL)	15.7 ± 5	12.7 ± 5.4^a	−3 ± 5.8	13.7 ± 4.8	−2 ± 5.3	13.9 ± 4.9	12.1 ± 6	−1.8 ± 5.7	12.4 ± 4.2	−1.5 ± 3.5
Albumin (g/dL)	3.5 ± 0.29	3.7 ± 0.46^a	0.21 ± 0.34	3.7 ± 0.35^a	0.16 ± 0.25	3.3 ± 0.25	3.7 ± 0.38^b	0.29 ± 0.32	3.7 ± 0 .33^b	0.28 ± 0.22
Phosphorus (mg/dL)	6.4 ± 2.8	5.7 ± 2.5	−0.68 ± 2.4	5.7 ± 1.9	−0.67 ± 2.6	6.2 ± 2.7	5.5 ± 2.3	−0.65 ± 3.1	6.4 ± 2	0.20 ± 2.6
Potassium (mmol/dL)	6 (5.4–6.3)	5.1 (4.5–5.8)	−0.6 (−1–0.5)	5.9 (5.2–6.7)	0.0 (−0.8–0.7)	5.5 (4.9–6)	5 (4.4–6)	−0.1 (−0.65–0.30)	5.1 (4.8–5.4)	−0.2 (−1–0.15)

ONS

ONS + RE

Baseline (n = 19)

6 weeks (n = 19)

Δ^c

12 weeks (n = 19)

Δ^d

Baseline (n = 17)

6 weeks (n = 17)

Δ^c

12 weeks (n = 17)

Δ^d

Hemoglobin (g/dL)

8.1 (7–10)

9.2 (8–10)^a

1.1 (−0.4–2.8)

8.4 (7.4–10)

0.2 (−0.7–1.2)

7.4 (6.6–9.1)

9 (7.6–10)^b

1.1 (0.3–1.7)

9 (7.7–10)

1.3 (−0.05–2.3)

Total lymphocytescount (cells/mm³)

977.6 (767–1165)

878.4 (764–1068)

−81.4 (−317.1–220.3)

996.3 (886.2–1161)

35.3 (−140.5–228.6)

702 (586.5–1022.85)

877.2 (654.5–1014)

50.1 (−169.8–203.2)

720 (637.2–798.5)

−25.5 (319.3–68.55)

Creatinine (mg/dL)

15.7 ± 5

12.7 ± 5.4^a

−3 ± 5.8

13.7 ± 4.8

−2 ± 5.3

13.9 ± 4.9

12.1 ± 6

−1.8 ± 5.7

12.4 ± 4.2

−1.5 ± 3.5

Albumin (g/dL)

3.5 ± 0.29

3.7 ± 0.46^a

0.21 ± 0.34

3.7 ± 0.35^a

0.16 ± 0.25

3.3 ± 0.25

3.7 ± 0.38^b

0.29 ± 0.32

3.7 ± 0 .33^b

0.28 ± 0.22

Phosphorus (mg/dL)

6.4 ± 2.8

5.7 ± 2.5

−0.68 ± 2.4

5.7 ± 1.9

−0.67 ± 2.6

6.2 ± 2.7

5.5 ± 2.3

−0.65 ± 3.1

6.4 ± 2

0.20 ± 2.6

Potassium (mmol/dL)

6 (5.4–6.3)

5.1 (4.5–5.8)

−0.6 (−1–0.5)

5.9 (5.2–6.7)

0.0 (−0.8–0.7)

5.5 (4.9–6)

5 (4.4–6)

−0.1 (−0.65–0.30)

5.1 (4.8–5.4)

−0.2 (−1–0.15)

	ONS	ONS + RE
Hemoglobin (g/dL)	8.1 (7–10)	9.2 (8–10)^a	1.1 (−0.4–2.8)	8.4 (7.4–10)	0.2 (−0.7–1.2)	7.4 (6.6–9.1)	9 (7.6–10)^b	1.1 (0.3–1.7)	9 (7.7–10)	1.3 (−0.05–2.3)
Total lymphocytescount (cells/mm³)	977.6 (767–1165)	878.4 (764–1068)	−81.4 (−317.1–220.3)	996.3 (886.2–1161)	35.3 (−140.5–228.6)	702 (586.5–1022.85)	877.2 (654.5–1014)	50.1 (−169.8–203.2)	720 (637.2–798.5)	−25.5 (319.3–68.55)
Creatinine (mg/dL)	15.7 ± 5	12.7 ± 5.4^a	−3 ± 5.8	13.7 ± 4.8	−2 ± 5.3	13.9 ± 4.9	12.1 ± 6	−1.8 ± 5.7	12.4 ± 4.2	−1.5 ± 3.5
Albumin (g/dL)	3.5 ± 0.29	3.7 ± 0.46^a	0.21 ± 0.34	3.7 ± 0.35^a	0.16 ± 0.25	3.3 ± 0.25	3.7 ± 0.38^b	0.29 ± 0.32	3.7 ± 0 .33^b	0.28 ± 0.22
Phosphorus (mg/dL)	6.4 ± 2.8	5.7 ± 2.5	−0.68 ± 2.4	5.7 ± 1.9	−0.67 ± 2.6	6.2 ± 2.7	5.5 ± 2.3	−0.65 ± 3.1	6.4 ± 2	0.20 ± 2.6
Potassium (mmol/dL)	6 (5.4–6.3)	5.1 (4.5–5.8)	−0.6 (−1–0.5)	5.9 (5.2–6.7)	0.0 (−0.8–0.7)	5.5 (4.9–6)	5 (4.4–6)	−0.1 (−0.65–0.30)	5.1 (4.8–5.4)	−0.2 (−1–0.15)

Table 3.

Open in new tab

Changes in biochemical parameters during the study

	ONS					ONS + RE
	Baseline (n = 19)	6 weeks (n = 19)	Δ^c	12 weeks (n = 19)	Δ^d	Baseline (n = 17)	6 weeks (n = 17)	Δ^c	12 weeks (n = 17)	Δ^d
Hemoglobin (g/dL)	8.1 (7–10)	9.2 (8–10)^a	1.1 (−0.4–2.8)	8.4 (7.4–10)	0.2 (−0.7–1.2)	7.4 (6.6–9.1)	9 (7.6–10)^b	1.1 (0.3–1.7)	9 (7.7–10)	1.3 (−0.05–2.3)
Total lymphocytescount (cells/mm³)	977.6 (767–1165)	878.4 (764–1068)	−81.4 (−317.1–220.3)	996.3 (886.2–1161)	35.3 (−140.5–228.6)	702 (586.5–1022.85)	877.2 (654.5–1014)	50.1 (−169.8–203.2)	720 (637.2–798.5)	−25.5 (319.3–68.55)
Creatinine (mg/dL)	15.7 ± 5	12.7 ± 5.4^a	−3 ± 5.8	13.7 ± 4.8	−2 ± 5.3	13.9 ± 4.9	12.1 ± 6	−1.8 ± 5.7	12.4 ± 4.2	−1.5 ± 3.5
Albumin (g/dL)	3.5 ± 0.29	3.7 ± 0.46^a	0.21 ± 0.34	3.7 ± 0.35^a	0.16 ± 0.25	3.3 ± 0.25	3.7 ± 0.38^b	0.29 ± 0.32	3.7 ± 0 .33^b	0.28 ± 0.22
Phosphorus (mg/dL)	6.4 ± 2.8	5.7 ± 2.5	−0.68 ± 2.4	5.7 ± 1.9	−0.67 ± 2.6	6.2 ± 2.7	5.5 ± 2.3	−0.65 ± 3.1	6.4 ± 2	0.20 ± 2.6
Potassium (mmol/dL)	6 (5.4–6.3)	5.1 (4.5–5.8)	−0.6 (−1–0.5)	5.9 (5.2–6.7)	0.0 (−0.8–0.7)	5.5 (4.9–6)	5 (4.4–6)	−0.1 (−0.65–0.30)	5.1 (4.8–5.4)	−0.2 (−1–0.15)

	ONS					ONS + RE
	Baseline (n = 19)	6 weeks (n = 19)	Δ^c	12 weeks (n = 19)	Δ^d	Baseline (n = 17)	6 weeks (n = 17)	Δ^c	12 weeks (n = 17)	Δ^d
Hemoglobin (g/dL)	8.1 (7–10)	9.2 (8–10)^a	1.1 (−0.4–2.8)	8.4 (7.4–10)	0.2 (−0.7–1.2)	7.4 (6.6–9.1)	9 (7.6–10)^b	1.1 (0.3–1.7)	9 (7.7–10)	1.3 (−0.05–2.3)
Total lymphocytescount (cells/mm³)	977.6 (767–1165)	878.4 (764–1068)	−81.4 (−317.1–220.3)	996.3 (886.2–1161)	35.3 (−140.5–228.6)	702 (586.5–1022.85)	877.2 (654.5–1014)	50.1 (−169.8–203.2)	720 (637.2–798.5)	−25.5 (319.3–68.55)
Creatinine (mg/dL)	15.7 ± 5	12.7 ± 5.4^a	−3 ± 5.8	13.7 ± 4.8	−2 ± 5.3	13.9 ± 4.9	12.1 ± 6	−1.8 ± 5.7	12.4 ± 4.2	−1.5 ± 3.5
Albumin (g/dL)	3.5 ± 0.29	3.7 ± 0.46^a	0.21 ± 0.34	3.7 ± 0.35^a	0.16 ± 0.25	3.3 ± 0.25	3.7 ± 0.38^b	0.29 ± 0.32	3.7 ± 0 .33^b	0.28 ± 0.22
Phosphorus (mg/dL)	6.4 ± 2.8	5.7 ± 2.5	−0.68 ± 2.4	5.7 ± 1.9	−0.67 ± 2.6	6.2 ± 2.7	5.5 ± 2.3	−0.65 ± 3.1	6.4 ± 2	0.20 ± 2.6
Potassium (mmol/dL)	6 (5.4–6.3)	5.1 (4.5–5.8)	−0.6 (−1–0.5)	5.9 (5.2–6.7)	0.0 (−0.8–0.7)	5.5 (4.9–6)	5 (4.4–6)	−0.1 (−0.65–0.30)	5.1 (4.8–5.4)	−0.2 (−1–0.15)

Biochemical indicators are mean ± SD or median (ﬁrst and third quartiles). No statistical difference was found in deltas between groups.

ONS, oral nutritional supplementation; ONS + RE; oral nutritional supplementation plus resistance exercise.

^aP < 0.05, compared with the ONS group at baseline.

^bP < 0.05, compared with the ONS + RE group at baseline.

^cΔ = difference between baseline and 6 weeks.

^dΔ = difference between baseline and 12 weeks.

This Feature Is Available To Subscribers Only